ADBiotech Co

ADBiotech Co Equity Ratio

The Equity Ratio of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is 31.65 %. In the previous year, Equity Ratio was 20.96 % — a change of 51.01% (higher).

Equity Ratio

31.65 %

YoY

51.01%

Last updated:

Equity Ratio of ADBiotech Co is 2025 31.65 % . Equity Ratio of ADBiotech Co was 2024 20.96 % . It decreases by 51.01% higher compared to the previous year.

The ADBiotech Co Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
46.64 KRW
Jan 1, 2019
61.50 KRW
Jan 1, 2020
49.51 KRW
Jan 1, 2021
24.36 KRW
Jan 1, 2022
52.18 KRW
Jan 1, 2023
47.67 KRW
Jan 1, 2024
20.96 KRW
Jan 1, 2025
31.65 KRW
The ADBiotech Co Equity Ratio history
YEAREquity RatioYoY
31.65 %+51.01%
20.96 %-56.03%
47.67 %-8.64%
52.18 %+114.21%
24.36 %-50.80%
49.51 %-19.50%
61.50 %+31.85%
46.64 %+5.94%
44.03 %+39.16%
31.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Equity Ratio of ADBiotech Co is 31.65 % in 2025.

Equity Ratio of ADBiotech Co changed from 20.96 % to 31.65 %, representing a 51.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's ADBiotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — ADBiotech Co

All Key Metrics — ADBiotech Co